At the moment, some medications can collaborate in the treatment of MASLD, some of them approved for the treatment of comorbidities such as GLP-1 agonists indicated for the treatment of T2DM or obesity, but also with benefit in the MASH treatment (9, 10)
GIP receptors are found in white adipose tissue, and their activation is thought to improve the "plasticity" of fat cells, allowing them to store lipids more effectively and reducing systemic inflammation
Because tirzepatide produces greater average weight loss than semaglutide, the aesthetic changes linked to weight loss magnitude (facial volume, skin laxity, hair shedding) may be more pronounced with tirzepatide in some patients
These injections combine essential B12 with lipotropic nutrients that support fat breakdown, liver function, and cellular energy, making them a powerful option for those looking to improve vitality and metabolic support